New eye implant combo tested for glaucoma pressure control
NCT ID NCT06066645
Summary
This study is testing whether adding a slow-release medication implant (iDose TR) to an existing drainage device (iStent infinite) works better than the drainage device alone for controlling eye pressure in glaucoma. The trial involves 230 adults with open-angle glaucoma or high eye pressure who have already received the iStent device. Participants will be randomly assigned to receive either the additional medication implant or a sham procedure and followed for 12 months to compare safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Clinical Study Site
RECRUITINGColorado Springs, Colorado, 80907, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.